对迪杰斯特拉等人的评论。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，第66期。
Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66.
作者信息
Bouva Marelle J, Maase Rose E, van Elburg Ruurd M
机构信息
Department Public Health Genomics & Screening, Centre for Health Protection, National Institute for Public Health and the Environment, 3720 BA Bilthoven, The Netherlands.
出版信息
Int J Neonatal Screen. 2024 Sep 24;10(4):65. doi: 10.3390/ijns10040065.
Abstract
The assessment of newborn screening (NBS) algorithms' performance to ensure quality improvements is a continuous process: false-positive referrals can enable optimisations in the shorter term, but false-negative referrals are often only discovered many years after the screening has taken place [...].
摘要
评估新生儿筛查（NBS）算法的性能以确保质量改进是一个持续的过程：假阳性转诊可在短期内实现优化，但假阴性转诊往往在筛查进行多年后才被发现[……]。
相似文献
1
Comment on Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66.对迪杰斯特拉等人的评论。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，第66期。
Int J Neonatal Screen. 2024 Sep 24;10(4):65. doi: 10.3390/ijns10040065.
2
Reply to Bouva et al. Comment on "Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66".对布瓦等人的回复。关于“迪克斯特拉等人。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，，66”的评论
Int J Neonatal Screen. 2024 Sep 24;10(4):66. doi: 10.3390/ijns10040066.
3
A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.1型酪氨酸血症的新生儿筛查假阴性——需要用琥珀酰丙酮重新评估新生儿筛查
Int J Neonatal Screen. 2023 Dec 4;9(4):66. doi: 10.3390/ijns9040066.
4
Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.琥珀酰丙酮作为检测新生儿I型酪氨酸血症的主要标志物及其在新生儿筛查项目中的测定。
Mol Genet Metab. 2014 Sep-Oct;113(1-2):67-75. doi: 10.1016/j.ymgme.2014.07.010. Epub 2014 Jul 17.
5
The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs.在扩大的新生儿筛查项目中纳入琥珀酰丙酮作为I型酪氨酸血症的标志物。
Rapid Commun Mass Spectrom. 2008;22(6):812-8. doi: 10.1002/rcm.3428.
6
Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.肝肾型酪氨酸血症的新生儿筛查：琥珀酰丙酮的串联质谱定量分析
Clin Chem. 2006 Mar;52(3):482-7. doi: 10.1373/clinchem.2005.059790. Epub 2006 Jan 26.
7
Newborn screening for Tyrosinemia type 1 using succinylacetone - a systematic review of test accuracy.使用琥珀酰丙酮对1型酪氨酸血症进行新生儿筛查——检测准确性的系统评价
Orphanet J Rare Dis. 2017 Mar 9;12(1):48. doi: 10.1186/s13023-017-0599-z.
8
Comment on Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. 2022, , 20.对琼斯等人的评论。一种用于在欧洲扩大遗传性代谢疾病新生儿筛查的新算法的应用。2022年，，20。
Int J Neonatal Screen. 2023 Feb 15;9(1):7. doi: 10.3390/ijns9010007.
9
The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening.琥珀酰丙酮的重要性：新生儿筛查正常后出现高胰岛素血症和多器官功能衰竭的I型酪氨酸血症
Int J Neonatal Screen. 2020 Jun;6(2). doi: 10.3390/ijns6020039. Epub 2020 May 16.
10
[Application of succinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1].[血液和尿液中琥珀酰丙酮水平测定在1型酪氨酸血症诊断中的应用]
Zhonghua Er Ke Za Zhi. 2012 Feb;50(2):126-30.
引用本文的文献
1
Reply to Bouva et al. Comment on "Dijkstra et al. A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone. 2023, , 66".对布瓦等人的回复。关于“迪克斯特拉等人。1型酪氨酸血症新生儿筛查假阴性——需要重新评估使用琥珀酰丙酮进行的新生儿筛查。2023年，，66”的评论
Int J Neonatal Screen. 2024 Sep 24;10(4):66. doi: 10.3390/ijns10040066.
本文引用的文献
1
A False-Negative Newborn Screen for Tyrosinemia Type 1-Need for Re-Evaluation of Newborn Screening with Succinylacetone.1型酪氨酸血症的新生儿筛查假阴性——需要用琥珀酰丙酮重新评估新生儿筛查
Int J Neonatal Screen. 2023 Dec 4;9(4):66. doi: 10.3390/ijns9040066.
Zotero 插件